446 related articles for article (PubMed ID: 25202979)
1. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
Kenny HA; Chiang CY; White EA; Schryver EM; Habis M; Romero IL; Ladanyi A; Penicka CV; George J; Matlin K; Montag A; Wroblewski K; Yamada SD; Mazar AP; Bowtell D; Lengyel E
J Clin Invest; 2014 Oct; 124(10):4614-28. PubMed ID: 25202979
[TBL] [Abstract][Full Text] [Related]
2. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.
Kenny HA; Kaur S; Coussens LM; Lengyel E
J Clin Invest; 2008 Apr; 118(4):1367-79. PubMed ID: 18340378
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis.
Bajwa P; Kordylewicz K; Bilecz A; Lastra RR; Wroblewski K; Rinkevich Y; Lengyel E; Kenny HA
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795484
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F
Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865
[TBL] [Abstract][Full Text] [Related]
5. Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.
Kenny HA; Krausz T; Yamada SD; Lengyel E
Int J Cancer; 2007 Oct; 121(7):1463-72. PubMed ID: 17546601
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis.
Kitami K; Yoshihara M; Tamauchi S; Sugiyama M; Koya Y; Yamakita Y; Fujimoto H; Iyoshi S; Uno K; Mogi K; Ikeda Y; Yokoi A; Yoshikawa N; Nishino K; Niimi K; Nawa A; Enomoto A; Kajiyama H
Matrix Biol; 2022 May; 109():70-90. PubMed ID: 35339636
[TBL] [Abstract][Full Text] [Related]
7. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
[TBL] [Abstract][Full Text] [Related]
8. HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling.
Terri M; Sandoval P; Bontempi G; Montaldo C; Tomero-Sanz H; de Turris V; Trionfetti F; Pascual-Antón L; Clares-Pedrero I; Battistelli C; Valente S; Zwergel C; Mai A; Rosanò L; Del Pozo MÁ; Sánchez-Álvarez M; Cabañas C; Tripodi M; López-Cabrera M; Strippoli R
J Exp Clin Cancer Res; 2024 Jan; 43(1):27. PubMed ID: 38254102
[TBL] [Abstract][Full Text] [Related]
9. Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation.
Dehghani-Ghobadi Z; Sheikh Hasani S; Arefian E; Hossein G
Cells; 2022 Jan; 11(2):. PubMed ID: 35053353
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta1 produced in autocrine/paracrine manner affects the morphology and function of mesothelial cells and promotes peritoneal carcinomatosis.
Na D; Lv ZD; Liu FN; Xu Y; Jiang CG; Sun Z; Miao ZF; Li F; Xu HM
Int J Mol Med; 2010 Sep; 26(3):325-32. PubMed ID: 20664947
[TBL] [Abstract][Full Text] [Related]
11. Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment.
Hilliard TS; Kowalski B; Iwamoto K; Agadi EA; Liu Y; Yang J; Asem M; Klymenko Y; Johnson J; Shi Z; Marfowaa G; Yemc MG; Petrasko P; Stack MS
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830322
[TBL] [Abstract][Full Text] [Related]
12. Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
Nakamura K; Sawada K; Kinose Y; Yoshimura A; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Morishige KI; Kurachi H; Lengyel E; Kimura T
Mol Cancer Res; 2017 Jan; 15(1):78-92. PubMed ID: 27758876
[TBL] [Abstract][Full Text] [Related]
13. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.
Barbolina MV; Adley BP; Ariztia EV; Liu Y; Stack MS
J Biol Chem; 2007 Feb; 282(7):4924-4931. PubMed ID: 17158885
[TBL] [Abstract][Full Text] [Related]
14. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer.
Cannistra SA; Ottensmeier C; Niloff J; Orta B; DiCarlo J
Gynecol Oncol; 1995 Aug; 58(2):216-25. PubMed ID: 7542622
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.
Do TV; Kubba LA; Du H; Sturgis CD; Woodruff TK
Mol Cancer Res; 2008 May; 6(5):695-705. PubMed ID: 18505915
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1.
Wang C; Wang J; Shen X; Li M; Yue Y; Cheng X; Lu W; Wang X; Xie X
J Exp Clin Cancer Res; 2021 Mar; 40(1):101. PubMed ID: 33726799
[TBL] [Abstract][Full Text] [Related]
18. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.
Cai J; Tang H; Xu L; Wang X; Yang C; Ruan S; Guo J; Hu S; Wang Z
Carcinogenesis; 2012 Jan; 33(1):20-9. PubMed ID: 22021907
[TBL] [Abstract][Full Text] [Related]
19. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro.
Strobel T; Cannistra SA
Gynecol Oncol; 1999 Jun; 73(3):362-7. PubMed ID: 10366461
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.
John B; Naczki C; Patel C; Ghoneum A; Qasem S; Salih Z; Said N
Oncogene; 2019 May; 38(22):4366-4383. PubMed ID: 30765860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
